跳至主要内容
临床试验/NCT03807349
NCT03807349终止不适用

N-Force Screws Augmented With N-Force Blue in Intracapsular Proximal Femur Fracture Treatment

Zimmer Biomet8 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2019年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Zimmer Biomet
入组人数
12
试验地点
8
主要终点
Number of Participants With a Reoperation

研究概览

简要总结

The objective of this prospective study is to confirm safety and performance of N-Force Screws augmented with N-Force Blue applied in intracapsular proximal femur fracture treatment.

详细描述

Primary Endpoint:

• Re-operation within 12 months after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function.

Secondary Endpoints:

  • Radiographic and clinical fracture healing of the proximal femur using standard scoring methods and patient satisfaction.
  • Cost effectiveness

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has primary Garden I or II intracapsular proximal femur fracture requiring surgical intervention and is eligible for fixation by three cannulated screws augmented with N-Force Blue.
  • Patient receives operative treatment within 7 days of injury.
  • Patient was ambulatory before injury.
  • Patient is 50 years of age or older.

排除标准

  • Patient has Garden III or IV intracapsular proximal femur fracture.
  • Patient has major cognitive impairment (including dementia).
  • Patient is on dialysis.
  • Patient is not expected to survive follow-up schedule.
  • Patient is expected to have problems maintaining follow-up compliance, i.e. patients with no fixed address, patients not mentally competent to give informed consent, etc. (Investigator's discretion).
  • Patient is a prisoner.
  • Patient is known to be pregnant and/or breastfeeding.
  • Patient is a known alcohol or drug abuser.
  • Patient had previous/has active acute or chronic infections, especially at the site of operation.
  • Patient has non-viable bone, or has areas where surrounding bone is not viable or capable of supporting and anchoring the implant.
  • Patient has traumatic injuries with open wounds or close to the proximal femur fracture, which are likely to become infected.
  • Patient is expected to be non-compliant with recommended post-operative weight-bearing instructions.
  • Physical conditions, in the opinion of the investigator, that would prohibit adequate implant support or impede healing.

结局指标

主要结局

Number of Participants With a Reoperation

时间窗: 12 months

Reoperation after initial surgery to promote fracture healing, relieve pain, treat infection, or improve function.

次要结局

  • Average Harris Hips Score (Clinical Fracture Healing of the Intracapsular Femur)(6 weeks, 3 months, 6 months, and 12 months)
  • Cost-Effective Analysis(12 months)
  • Participant Steinberg Classification at 12 Months(12 months)
  • Average EQ-5D-5L Score (Clinical Fracture Healing of the Intracapsular Femur)(6 weeks, 3 months, 6 months, and 12 months)
  • Number of Participants That Performed Timed Up-and-Go Test (Clinical Fracture Healing of the Intracapsular Femur)(6 weeks, 3 months, 6 months, and 12 months)
  • Number of Participants With Radiographic Fracture Healing of the Intracapsular Femur (RUSH)(6 weeks, 3 months, 6 months, and 12 months)
  • Average FIX-IT Score (Clinical Fracture Healing of the Intracapsular Femur)(6 weeks, 3 months, 6 months, and 12 months)
  • Average Participant Time to Complete Timed Up-and-Go Test (Clinical Fracture Healing of the Intracapsular Femur)(6 weeks, 3 months, 6 months, and 12 months)

研究者

发起方
Zimmer Biomet
申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验